Search research articles
Contact Us
Filters
Showing results (181-190 of 299) with videos related to
Page
of 30
Sort By:
Cancer Research
|
June 1, 1989
Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines
C M Boyer, D V Dawson, S E Neal, et al.
Bone Marrow Transplantation
|
December 1, 1995
Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy
J J Vredenburgh, W P Peters, G Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis
F J Xu, S Stack, C Boyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1985
Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma
H Sekine, D F Hayes, T Ohno, et al.
American Journal of Obstetrics and Gynecology
|
April 1, 1994
Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas
J R Wiener, J A Hurteau, B J Kerns, et al.
Blood
|
May 1, 1985
Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement
P De Fabritiis, M Bregni, J Lipton, et al.
American Journal of Obstetrics and Gynecology
|
February 11, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer
A Berchuck, G C Rodriguez, A Kamel, et al.
Cancer Research
|
May 30, 1998
Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines
S E Patton, M L Martin, L L Nelsen, et al.
American Journal of Clinical Pathology
|
June 1, 1993
Determination of proliferation index in advanced ovarian cancer using quantitative image analysis
P A Jordan, B J Kerns, J C Pence, et al.
Immunology Series
|
January 1, 1994
Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer
R C Bast, F Xu, Y Yu, et al.
Page
of 30
Search research articles
Search
Showing results (181-190 of 299) with videos related to
Sort By:
Page
of 30
Cancer Research
|
June 1, 1989
Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines
C M Boyer, D V Dawson, S E Neal, et al.
Bone Marrow Transplantation
|
December 1, 1995
Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy
J J Vredenburgh, W P Peters, G Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis
F J Xu, S Stack, C Boyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1985
Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma
H Sekine, D F Hayes, T Ohno, et al.
American Journal of Obstetrics and Gynecology
|
April 1, 1994
Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas
J R Wiener, J A Hurteau, B J Kerns, et al.
Blood
|
May 1, 1985
Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement
P De Fabritiis, M Bregni, J Lipton, et al.
American Journal of Obstetrics and Gynecology
|
February 11, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer
A Berchuck, G C Rodriguez, A Kamel, et al.
Cancer Research
|
May 30, 1998
Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines
S E Patton, M L Martin, L L Nelsen, et al.
American Journal of Clinical Pathology
|
June 1, 1993
Determination of proliferation index in advanced ovarian cancer using quantitative image analysis
P A Jordan, B J Kerns, J C Pence, et al.
Immunology Series
|
January 1, 1994
Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer
R C Bast, F Xu, Y Yu, et al.
Page
of 30